TSG Therapeutics
The business, the turning points, and the decisions behind them.
Some sections are still being researched3 / 4
Sections to complete：02 · 03 · 05
01 / WHAT IT BUILT
What the company did
TSG Therapeutics Pte. Ltd. is a Singapore biopharmaceutical company incorporated in April 2016, pioneering broad-spectrum medicines for viral infectious diseases — especially neglected ones. Its technology targets mosquito-borne infections including Zika, Dengue, Yellow Fever, Japanese Encephalitis and Chikungunya, plus other intractable viruses such as Rabies, rejecting the narrow 'one bug, one drug' model for a broad-spectrum vision. Listed by the World Economic Forum, the company remains active with share capital of about $5.8 million.
02 / FAILURE REASONS
Material for this section is being gathered and checked. It will appear here once ready.
03 / EVENT HISTORY
Material for this section is being gathered and checked. It will appear here once ready.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / CAUSAL CHAIN / AFTERMATH
Material for this section is being gathered and checked. It will appear here once ready.